The SOAP Project*, funded by the European Commission, would like to announce the release of an online survey to assess researchers' experiences with open access publishing. This survey aims to inform the most comprehensive analysis of attitudes to open access publishing to date and is seeking views from a wide a range of interested parties. It is primarily aimed at active researchers in public and private organisations, from all research fields in science and the humanities and focuses on publication of research articles in (open access) peer-reviewed journals.
If you would like to contribute to shaping the public discourse on open access, please visit http://surveymonkey.com/soap_survey_d. It should take 10-15 minutes to complete. The SOAP Project team would appreciate if you would share this link with your colleagues and collaborators so that the views of your discipline are properly represented.
The survey outcome will be made public and the resulting insights as well as recommendations will be openly shared with the European Commission, publishers, research funding agencies, libraries and researchers.
Thanks in advance, the SOAP Project Team info@project-soap.eu
* The SOAP consortium is coordinated by CERN, the European Organisation for Nuclear Research. It represents key stakeholders in open access, such as publishers BioMed Central, SAGE and Springer; funding agencies (the UK Science and Technology Facilities Council) and libraries (the Max Planck Digital Library of the Max Planck Society). The project runs for two years, from March 2009 to February 2011.
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.